CME Programme
-
Regular Activities
Legacy of TAGRISSO: Hope for EGFR-mutated NSCLC PatientsDate: 18/07/2022 Enquiries: AstraZeneca (Hong Kong) CME Points Awarded: 2 points
CME Programme
Date: | 18/07/2022 |
Enquiries: | AstraZeneca (Hong Kong) |
CME Points Awarded: | 2 points |